Tagged with A

Pharma International Co. (PIC) You took over from your father in 2006. What have been the key milestones & achievements in the company’s development since then and how does your approach differentiate from your father’s? I joined Pharma International in 2006. We had already started our production in 2000. Previously we had a British…

Jordan Investment Board The Jordan Investment Board (JIB) has played an important role in boosting the success story of the Jordanian economy since its inception in 1995; today, what are the JIB’s main priorities and objectives? What is currently your core agenda? The JIB attracts FDI to Jordan from all over the world.…

Gulf Organization for Industrial Consulting What was the vision behind the creation of GOIC back in 1976 by the 6 Gulf States (Bahrein, KSA, UAE, Oman, Kuwait and Qatar)? How did you 6 States see the need for such an organization, which is like a knowledge-hub that would promote trade and investment by enabling the…

Hikma The company success is built on a unique and daring strategy initiated by your father. The company saw itself as a multinational company instead of a domestic company from the start, and pushed into the US. Your dad initiated the strategy, now you have the reigns to follow up on…

Dar Al Dawa Development & Investment Dar al Dawa is the second biggest Jordanian pharmaceutical manufacturer. What are the main factors that allowed you to be so successful and remain in one of the top positions since the company’s inception in 1974? The key factor has been Jordan. Being poor in natural recourses, Jordan had to…

Pierre Fabre Farma de México Please can you give us a brief rundown of Pierre Fabre’s activities in Mexico since they opened an affiliate here, specifically the company’s milestones and achievements along the way? Pierre Fabre (PF) is now celebrating its 51st anniversary as 2012 rolls in. A French based company founded by Mr. Pierre…

Hormona Laboratorios Since we last spoke to you in 2008, Mexico has undergone a lot of regulatory changes, and we witnessed the rise of Seguro Popular, and the rise of COFEPRIS for example. What has been the biggest change in the market in the last 4 years, and how have these changes…

Sanofi Pasteur Thailand You moved from the post of President for Sanofi Pasteur in Korea to President of Sanofi Pasteur in Thailand 1,5 years back. What have been the milestones so far and what have been the most important lessons learnt? Thailand is a country of dynamism. Thai people are very professional and…

Quintiles Thailand Asia is rapidly becoming a new frontier for drug development as Western companies seek to develop and register their products in Asia, while emerging Asian companies seek new capabilities to globalize products. We hear a lot of positive sounds and enthusiasm from MNCs about the environment in Thailand: available pool…

AstraZeneca Thailand Dr. Seeto, this is your first head of country position for AZ! Looking back at your first year-and-a-month, what have been the highlights and the key lessons learnt? Firstly, leading the Thai country organization has been a real privilege and honor. Looking back, I am proud of how the country…

The Government Pharmaceutical Organization (G Dr. Witit, when we interviewed your predecessor in 2006, we talked about the vital role and leading position GPO plays in the Thai pharmaceutical industry and the company’s investments in manufacturing facilities to improve access and affordability of drugs. What have been some of the most important milestones since you…

Zuellig Pharma Thailand ‘When markets are inefficient, relationships are important. When markets are more efficient, relationships become less important because the markets become more systematic, professional, and objective in the way they operate,’ said Mr. Zwisler, former CEO of Zuellig Pharma Asia Pacific when we interviewed him in China. At which development stage…